Brain Tumor Investment Fund (investor - Others)
		See something wrong or missing? Let us know
	
Offices:Boston
		
		
		
		
			Average round investment:56.41M USD
			Average number per year:1.0
			
				
					Distribution:
					2025 (1)2023 (1)
					
				
			
			
				
					Portfolio companies:
					 Trogenix
 Trogenix
					
				
			
			
				 Trogenix
 Trogenix
					
				
					Mostly invests in:
					 United Kingdom (2)
					Biotech (2)
 United Kingdom (2)
					Biotech (2)
				
			
		
	 United Kingdom (2)
					Biotech (2)
 United Kingdom (2)
					Biotech (2)
				2 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Brain Tumor Investment Fund
| Name | Criteria | |
|---|---|---|
|  | Allen & Company 83% | 
 | 
|  | Hercules Capital 83% | 
 | 
|  | Venture Science 83% | 
 | 
|  | Fearless Ventures 83% | 
 | 
|  | Integrated 83% | 
 | 
|  | Adage Capital Management 83% | 
 | 
|  | Negev Capital 83% | 
 | 
|  | Abingworth 83% | 
 | 
|  | National Resilience 83% | 
 | 
|  | Walden Catalyst Ventures 83% | 
 | 
 Belgium
 Belgium Netherlands
 Netherlands Austria
 Austria Germany
 Germany Switzerland
 Switzerland Denmark
 Denmark Estonia
 Estonia Finland
 Finland Iceland
 Iceland Latvia
 Latvia Lithuania
 Lithuania Norway
 Norway Sweden
 Sweden France
 France Ireland
 Ireland Italy
 Italy Portugal
 Portugal Spain
 Spain